Active Ingredient(s): Daunorubicin + Cytarabine
FDA Approved: * August 3, 2017
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vyxeos Overview

Daunorubicin, also known as daunomycin, is a chemotherapy medication used to treat cancer.[2] Specifically it is used for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myelogenous leukemia (CML), and Kaposi's sarcoma.[2] It is used by injection into a vein.[2] A liposomal formulation known as liposomal daunorubicin also exists.[2] Common side effects include hair loss, vomiting, bone marrow suppression...

Read more Vyxeos Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Daunorubicin

Recent Vyxeos Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Daunorubicin + Cytarabine
  • Injection, Liposomal: 44mg + 100mg
  • Powder: 100mg + 44mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Vyxeos: (1 result)

Sorted by National Drug Code
  • 68727-745 Vyxeos Intravenous Injection, Powder, Lyophilized, for Suspension by Jazz Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (9 results)